| ADLAI NORTYE LTD. SP.ADR |
| USA |
| Gesundheit |
| US00704R1095 / A3EEED |
| N2U0 (Frankfurt) / ANL (NASDAQ) |
| FRA:N2U0, ETR:N2U0, N2U0:GR, NASDAQ:ANL |
| - |
| https://www.adlainortye.c.. |
|
Adlai Nortye Ltd. ADR is the American Depositary Receipt representing shares of Adlai Nortye Ltd., a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative cancer therapies. The company leverages its dual R..
>Volltext.. |
| 252.54 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| ADLAI NORTYE |
| 06.04.26 |
|
||||
|